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 ABSTRACT 
Liver regeneration is a complex process that requires the coordinated expression 
of cytokines and growth factors.  One well-studied model of liver regeneration is partial 
hepatectomy (PH), in which removal of 70% of the liver initiates compensatory 
hepatocyte proliferation.  PH-induced liver regeneration requires the activation of 
resident macrophages (Kupffer cells), which produce cytokines that drive hepatocyte 
proliferation.  Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that is 
known to activate macrophages and recruit monocytes during tissue injury.  The goal of 
this study was to determine how MCP-1 contributes to macrophage activation during 
liver regeneration.  Results indicate that hepatic and plasma MCP-1 levels increased 
within 12 hr after PH and correlated with hepatic recruitment of cells expressing the 
MCP-1 receptor, CCR2.  Nevertheless, hepatocyte proliferation was comparable in MCP-
1 knockout and wild-type mice, as was the expression of Kupffer cell-derived cytokines.  
Furthermore, hepatic recruitment of CCR2+ cells was similar in MCP-1 knockout and 
wild-type mice, which suggests that other chemokines may efficiently recruit CCR2+ 
cells in the absence of MCP-1.  CCR2 appears to be required for optimal regeneration, as 
CCR2 knockout mice had levels of hepatocyte proliferation that were 50% lower than 
wild-type mice 36 hr after PH.  We conclude that MCP-1 is not required for macrophage 
activation during PH-induced liver regeneration.  Future studies should instead focus on 
mechanisms by which CCR2 signaling events and the hepatic recruitment of CCR2-
expressing cells facilitates hepatocyte proliferation during liver regeneration.  
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CHAPTER 1: INTRODUCTION 
Overview 
Liver regeneration is an amazing phenomenon, in which removal of a portion of 
the liver induces remaining cells to proliferate to restore organ mass.  The capacity of the 
liver to regenerate has been recognized for thousands of years.  In fact, it is referenced in 
the Greek myth of Prometheus, who was a titan accused of stealing fire from the gods of 
Mount Olympus.  As punishment for his treachery, Prometheus was tied to a rock, and 
his liver was eaten by an eagle each day only to grow back during the night, thus causing 
perpetual torment (Power & Rasko, 2008). 
While the human liver does not actually regenerate overnight, it does have the 
capacity to restore its mass and function within just a few months after widespread 
damage or tissue loss (Aoki et al., 2011).  The physiology of liver regeneration has been 
extensively investigated, but it is still not completely understood.  For example, the 
precise mechanisms that initiate and terminate regeneration have yet to be identified. 
Furthermore, the identification of these mechanisms is confounded by pathological 
factors, such as inflammation or viral disease, which often accompany human liver 
disease.  
Liver Anatomy and Physiology 
The liver performs several essential physiological functions.  One major function 
of the liver is to synthesize proteins.  In fact, almost all of the major plasma proteins are 
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produced in the liver.  These proteins include albumin, which is essential for maintaining 
osmotic pressure in the circulatory system, as well as transferrin, prothrombin, 
fibrinogen, lipoproteins and complement proteins.  The liver also functions in regulation 
of lipid, protein and glucose metabolism (Tacke, Luedde, & Trautwein, 2009), and it is 
richly populated with immune cells, allowing it to participate in both innate and adaptive 
immune responses (Tacke et al., 2009).  Finally, perhaps the most recognized function of 
the liver is detoxification of exogenous and endogenous compounds via the induction of a 
wide array of xenobiotic metabolizing enzymes, such as the cytochrome P450 enzyme 
family (Hakkola, Tanaka, & Pelkonen, 1998).  
Blood Flow Through the Liver 
The liver is a highly perfused organ.  Nutrient-rich blood from the gastrointestinal 
tract is routed to the liver through the hepatic portal vein, whereas oxygen-rich blood is 
delivered to the liver through the hepatic artery (Fig. 1.1).  Portal blood mixes with 
arterial blood in small, permeable capillaries, known as sinusoids, which permeate the 
liver.  Sinusoids deliver blood to the hepatocytes, enabling them to carry out metabolic 
processes. Blood then empties into central veins that coalesce into the hepatic vein, which 
returns blood to the systemic circulation (Wheatley et al., 1997). 
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Figure 1.1 Blood Flow Through the Liver.  Oxygenated blood is carried to the liver 
through the hepatic artery. Nutrient-rich, oxygen-poor blood is delivered from the 
intestines to the liver though the portal vein.  Blood mixes in small, permeable capillaries 
known as sinusoids. The sinusoids allow blood to flow from the portal triads to the 
central veins, which coalesce and drain into the hepatic vein, which returns blood to the 
systemic circulation. 
Bile Production 
In addition to receiving a dual blood supply, another interesting feature of the 
liver is its role in producing bile.  Hepatocytes use cholesterol to synthesize bile, which 
helps emulsify fats in the small intestine (Chiang, 2009).  Bile is collected from all areas 
of the liver through bile ductules, which coalesce and exit the liver through the common 
bile duct.  The liver architecture is divided into lobules, with each lobule receiving blood 
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and producing bile.  The lobules intersect each other at structures called portal triads, 
which consist of branches of the hepatic portal vein and hepatic artery, as well as a bile 
ductule (Fig. 1.1).  The abundance of portal triads throughout the liver ensures adequate 
perfusion of blood and efficient collection of bile. 
Hepatocytes 
The most common cell in the liver is the parenchymal hepatocyte, which 
comprises 60% of all liver cells and 80% of the liver volume (Ramadori & Saile, 2002).  
Hepatocytes are a specialized type of epithelial cell that stack tightly together to form 
plates that are separated by sinusoids.  Hepatocytes are polarized and have distinct apical, 
lateral, and basal surfaces that aid in uptake and secretion of substances.  The basal 
surface of the hepatocyte faces the sinusoid and contains microvilli that increase surface 
area to facilitate exchange of materials.  The apical surface also has many microvilli and 
faces the bile canaliculi (Ramadori & Saile, 2002).  The lateral surfaces of hepatocytes 
are connected by gap junctions to allow the flow of molecules between cells.  
Hepatocytes perform the bulk of liver functions including detoxification and plasma 
protein production. 
Nonparenchymal Cells 
While the most abundant type of cell in the liver is the parenchymal hepatocyte, 
other non-parenchymal cells exist and are important for liver homeostasis.  Non-
parenchymal cells comprise 35% of all liver cells and include sinusoidal endothelial cells, 
resident macrophages, hepatic stellate cells, and biliary epithelial cells, which are also 
called cholangiocytes (Fig. 1.2).  Other less abundant non-parenchymal cells include 
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immune cells, such as resident T cells and natural killer cells.  Non-parenchymal cells 
contribute to liver homeostasis through diverse mechanisms, such as regulation of blood 
flow, bile transport, vitamin A storage, and immune surveillance.  
Liver Sinusoid Endothelial Cells 
Liver sinusoid endothelial cells line the capillary sinusoids. These cells are highly 
fenestrated, which allows blood to easily exit the capillary lumen and bathe the 
surrounding sheets of hepatocytes, where nutrients and soluble factors are exchanged. 
Following liver injury, these cells are capable of proliferating, and additional progenitors 
are recruited from the bone marrow (DeLeve, 2013).  During liver regeneration, sinusoid 
endothelial cells not only proliferate, but also secrete soluble mediators, such as 
hepatocyte growth factor, which is a mitogen for hepatocyte proliferation. 
Hepatic Stellate Cells 
Hepatic stellate cells (HSC) reside between the LSEC and hepatocytes in an area 
referred to as the space of Disse.  In the healthy liver, HSCs store 80% of the body’s 
vitamin A as retinol esters (Friedman, 2008).  However, liver injury may induce these 
cells to assume a myofibroblast-like phenotype, characterized by the production of 
extracellular matrix proteins, such as collagen type I.  Indeed, HSCs are central to the 
wound healing response, and inappropriate activation of these cells plays a central role in 
the development of liver fibrosis (Kawser, Iredale, Winwood, & Arthur, 1998).  During 
liver regeneration, HSCs are thought to be an abundant producer of hepatocyte growth 
factor (Skrtic et al., 1997). 
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Biliary Epithelial Cells 
Biliary epithelial cells are non-parenchymal cells that line the bile ducts that 
transport bile to the small intestine (Katayanagi, Kono, & Nakanuma, 1998).  These cells 
are cuboidal epithelial cells that have been shown to secrete cytokines (Isse, Harada, & 
Nakanuma, 2007; Katayanagi et al., 1998).  These cells have been shown to proliferate 
and recruit leukocytes during several pathological conditions of the liver (Isse et al., 
2007).  
Immune Cells of the Liver 
Immune cells are an important component of the liver.  Because blood is 
delivered directly from the gastrointestinal tract to the liver, the liver is tasked with 
removing foreign substances and potential pathogens from the blood before it reaches the 
systemic circulation.  Resident immune cells, such as T and B lymphocytes, natural killer 
cells, and macrophages, are crucial for removing pathogens and initiating an adaptive 
immune response, if necessary.  
Resident macrophages in the liver, also known as Kupffer cells (KC), line the 
sinusoids and scavenge particulate debris in blood that enters the liver.  They are derived 
from circulating monocytes.  These cells play a critical role in detoxifying blood from the 
portal circulation.  In fact, large periportal KC are the first cells to encounter pathogens 
that reach the liver through the portal vein.  Upon contact with pathogens, KC become 
activated and secrete soluble mediators, such as tumor necrosis factor-α (TNFα), 
prostaglandin-E2, and interleukin (IL)-1.  Smaller KC are located near the central vein of 
liver lobules (Bilzer, Roggel, & Gerbes, 2006).  Although KC typically reside in the liver 
for up to 14 months, they are capable of replication (Dory et al., 2003).  Also, KC 
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numbers can be replenished when circulating monocytes enter the liver and differentiate 
into macrophages.  During liver regeneration, macrophages are critical sources of IL-6 
and TNFα, which are necessary for hepatocyte proliferation (Selzner et al., 2003). 
 
Figure 1.2 Cells of the Liver. The liver is comprised of several cell types. 
Parenchymal hepatocytes are arranged in sheets that are lined by sinusoidal capillaries. 
The sinusoidal epithelium is highly fenestrated and is lined with endothelial cells. 
Hepatic stellate cells are non-parenchymal cells found in the space of Disse between the 
hepatocytes and sinusoids.  Macrophages known as Kupffer cells line the sinusoidal 
endothelium. 
Regenerative Ability of the Liver 
The liver is constantly exposed to foreign material and potentially toxic 
chemicals, as it receives blood from the stomach and intestines.  Nevertheless, 
mammalian hepatocytes typically have low turnover (Malato et al., 2011).  However, 
hepatocyte proliferation may be induced depending on the severity of the insult.  The 
regenerative capacity of the liver may have evolved as protection against ingested 
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toxicants (Taub, 2004).  This regenerative process appears to depend on a complex 
symphony of soluble mediators and cellular events and has been well studied in animal 
models of partial hepatectomy (PH), in which a substantial portion (usually 70-80%) of 
the liver is resected.  After PH, resident nonparenchymal cells produce soluble mediators 
that signal the hepatocytes, as well as other cells in the liver, to proliferate in a fairly 
synchronized manner and restore liver mass. 
It is a hotly debated issue whether stem cells exist in the liver, and if so, how 
extensively they contribute to regeneration.  Observation of hepatocytes moving from 
periportal to centrilobular locations during maturation has been interpreted by some to be 
evidence of a stem cell population in the periportal region of the lobule (Sigal et al., 
1995).  Despite the continual research to discover a population of stem cells in the liver, it 
has been shown that existing, mature hepatocytes can replicate and restore liver mass 
without the involvement of stem cells (Sharma, Cantz, Manns, & Ott, 2006).  
One model system that demonstrates the proliferative capacity of mature 
hepatocytes is fumarylacetoacetate hydrolase-deficient mice (Overturf, AlDhalimy, Ou, 
Finegold, & Grompe, 1997).  Fumarylacetoacetate hydrolase is an enzyme that catalyzes 
the hydrolysis of 4-fumarylacetoacetate into fumarate and acetoacetate.  Without this 
enzyme, buildup of toxic metabolites leads to progressive liver damage and cell loss.  
When a small number of healthy adult hepatocytes were transplanted into the liver of 
fumarylacetoacetate hydrolase-deficient mice, the cells completely repopulated the liver 
and restored liver function (Overturf et al., 1997).  In fact, it was found that the cells 
could be serially transplanted from one enzyme-deficient mouse to another, which 
demonstrates the nearly limitless proliferative capacity of adult hepatocytes.   
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Liver regeneration following PH is referred to as compensatory regeneration, in 
which cells proliferate to restore lost organ mass. Compensatory hyperplasia occurs when 
large areas of the liver are damaged or physically removed.  A physiologically relevant 
event that could lead to compensatory hyperplasia is widespread liver necrosis due to the 
effects of a toxicant.  However, in the laboratory, surgical resection of the liver is 
typically preferred to chemical-induced necrosis for inducing regeneration because the 
excessive inflammatory response associated with necrosis can be a confounding factor in 
understanding normal regenerative processes.   
Compensatory regeneration should not be confused with two other types of 
regeneration: mitogen-induced hyperplasia and leading edge regeneration.  Mitogen-
induced hyperplasia refers to hepatocyte proliferation that occurs in response to mitogens 
in the absence of tissue injury or loss (Columbano et al., 1990).  In this type of 
hyperplasia, hepatocytes must overcome normal growth control mechanisms to 
proliferate, and under such conditions, the increased liver mass is called “augmentative 
hepatomegaly” (Michalopoulos, 2013). When the mitogen is removed, the original organ 
mass is restored as excess cells undergo apoptosis (Columbano, Leddacolumbano, Lee, 
Rajalakshmi, & Sarma, 1987).  Whereas the liver can undergo compensatory regeneration 
and mitogen-induced hyperplasia, it does not participate in leading-edge regeneration, in 
which only those cells that are positioned along a damaged edge of a tissue are capable of 
dividing.  A classic example of leading edge regeneration is limb regeneration in 
salamanders, in which amputation of the limb results in regrowth of the entire limb. This 
process is also analogous to limb development during embryogenesis (Nacu & Tanaka, 
2011). 
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PH Model of Liver Regeneration 
The 70% PH model has been extensively used to investigate mechanisms of liver 
regeneration (Michalopoulos, 2010).  In mice, 70% PH consists of surgical resecting 
three of the five main liver lobes (Greene & Puder, 2003).  Following resection, 
parenchymal and non-parenchymal cells in the remnant liver proliferate in a fairly 
synchronized manner.  Peak DNA synthesis in hepatocytes occurs within 24 hours in rats 
and 36 hours in mice (Mao, Glorioso, & Nyberg, 2014; Michalopoulos & DeFrances, 
1997).  The precise mechanisms by which liver regeneration is regulated, including the 
onset and termination of regeneration, are poorly understood.  Once the mass of the liver 
is restored, cells presumably receive signals that terminate their proliferation.  The 
proliferative process typically results in a slight overproduction of liver cells but is 
followed by a wave of apoptosis, which restores the liver to within 5% of its previous 
mass (Michalopoulos, 2013). 
Phases of Liver Regeneration 
Liver regeneration can be divided into two phases, referred to as priming and 
progression (Fig. 1.3), both of which are required for complete regeneration (Fausto, 
2000).  Priming refers to a collection of events that culminate in the movement of 
quiescent liver cells into the cell cycle, whereas progression refers to those events that 
facilitate continued progression through the cell cycle, resulting in actual cell division.  
Priming and Progression of Liver Regeneration 
Hepatocyte priming is mediated by the production of TNFα and IL-6 by Kupffer 
cells (Baier et al., 2005). These soluble mediators bind to their cognate receptors on 
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hepatocytes and induce the activity of transcription factors, such as NF-kB, STAT3, AP1, 
and CF/EBP-beta (Kountouras, Boura, & Lygidakis, 2001).  Changes in hepatocyte gene 
expression prepare these cells to respond to growth factors produced during the 
progression phase of regeneration.  For example, hepatocytes upregulate c-Met, which is 
the receptor for hepatocyte growth factor, and EGFR, which is the receptor for epidermal 
growth factor (Su, Guidotti, Pezacki, Chisari, & Schultz, 2002).  During the progression 
phase of regeneration, hepatocyte replication is dependent on the availability of these 
growth factors, as well as other soluble mediators (Fausto, Campbell, & Riehle, 2006).  
Termination of Liver Regeneration 
Termination of liver regeneration is precisely regulated, yet the mechanisms that 
halt hepatocyte proliferation are poorly understood.  Previous research implicated TGF-β 
due to its well known antiproliferative activity, but this has not been definitely proven 
(Macias-Silva, Li, Leu, Crissey, & Taub, 2002).  Recent evidence suggests a possible role 
for caspases, which are cysteine-aspartic proteases important for apoptosis, necrosis, and 
inflammation (Alnemri et al., 1996).  For example, caspase recruitment domain-
containing protein-11 was recently found to be upregulated during termination of liver 
regeneration (Nygard et al., 2012).  Nevertheless, the exact molecular mechanisms of this 
termination phase remain unclear.  
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Figure 1.3 Phases of Liver Regeneration. In the healthy liver, hepatocytes are 
quiescent. Removal of a substantial portion of the liver through PH induces macrophages 
to produce TNFα  and IL-6, which primes the hepatocytes for subsequent progression 
through the cell cycle, which is dependent on growth factors, such as hepatocyte growth 
factor (HGF) and epidermal growth factor (EGF). 
Monitoring Liver Regeneration 
Several methods can be used to monitor progression of liver regeneration.  A 
common measure is liver weight and the liver-body weight ratio.  While this method is 
straightforward, it can be influenced by factors not directly related to regeneration, such 
as glycogen and lipid content in the liver, as well as blood volume.  A commonly used 
approach for measuring liver regeneration is quantifying the number of proliferating 
hepatocytes.  This is often accomplished through the administration of the nucleotide 
analog bromodeoxyuridine (BrdU), which is incorporated into the newly synthesized 
DNA strand in place of thymidine (Assy & Minuk, 1997).  BrdU incorporation indicates 
that a hepatocyte has progressed to S-phase of the cell cycle and has successfully 
duplicated its DNA.  BrdU incorporation is typically quantified in hepatocytes using flow 
cytometry or immunohistochemistry.   
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Role of Macrophages in Liver Regeneration 
Macrophage Numbers Increase Following PH 
In healthy liver tissue, KC make up the largest population of nonparenchymal 
cells.  These liver cells maintain their population by self-renewal and also via recruitment 
of monocytes from the bone marrow or spleen (Naito, Hasegawa, & Takahashi, 1997). 
Following PH, the number of KC in the liver increases within 1 hour (Baier et al., 2005).  
There is another increase in the number of KC 6-12 hr following PH, and this increase is 
comprised mainly of activated cells (Baier et al., 2005).  It has been suggested that the 
early increase in macrophage number is due to the recruitment of monocytes, which are 
macrophage precursors, from the bone marrow (Minamino et al., 2012). The second 
increase is believed to result from proliferation of activated resident macrophages (Ukai 
et al., 1990). 
Macrophages Become Activated After PH 
It is hypothesized that changes in blood flow through the liver may be involved in 
priming hepatocytes after PH (Michalopoulos, 2010; Mochida, Ohta, Ogata, & Fujiwara, 
1992).  After removal of 70% of the liver, blood from the portal vein and hepatic artery is 
still being delivered to the liver at normal flow rates, despite the fact that the organ 
volume is markedly decreased, which results in increased intrahepatic pressure.  
Increased blood flow to the liver enhances the delivery of molecules that can potentially 
activate resident KC, including bacterial lipopolysaccharide (LPS), which is known to 
activate macrophages (Shiratori et al., 1996).  In fact, LPS is a well-known inducer of 
macrophage-derived IL-6 and TNFα, both of which are necessary for priming of 
 
14 
hepatocytes immediately following liver regeneration (Fujihara et al., 2003).  Increased 
intrahepatic pressure following PH can also stimulate KC to secrete vasoactive factors, 
such as heme oxygenase (HO)-1 and endothelial nitric oxide synthase (eNOS) 
(Abshagen, Eipel, Kalff, Menger, & Vollmar, 2008).  Kupffer cells are critical for 
regulating vascular permeability in the liver (Abshagen et al., 2008).  When KC are 
depleted, blood flow in liver sinusoids during regeneration is decreased (Abshagen et al., 
2008).  Hence, KC-mediated changes in microcirculation may be critical to initiation of 
liver regeneration via increased intrahepatic pressure or enhanced delivery of LPS. 
Macrophages Mediate the Priming Phase of Liver Regeneration 
Cells of the monocyte-macrophage lineage are necessary for priming hepatocytes 
during liver regeneration through the production of IL-6 and TNFα (Taub, 2004). First, 
TNFα is secreted by KC in response to activation by the bacterial antigen, LPS.  TNFα 
functions in an autocrine fashion to stimulate IL-6 secretion.  IL-6 binds to receptors on 
the cell surface of hepatocytes.  This leads to activation of STAT3, which is a 
transcription factor that drives the expression of immediate early genes that drive 
hepatocyte cell cycle progression.  These events are summarized in Figure 1.4. 
Numerous studies demonstrate that monocyte/macrophage-derived TNFα and IL-
6 are necessary for normal liver regeneration to proceed.  For example, in one study, mice 
were irradiated to destroy their immune cell populations, including monocytes and 
macrophages (Sudo et al., 2008).  Immune cells were repopulated through the transfer of 
bone marrow from wild-type, TNFα knockout, or IL-6 knockout mice, and the mice were 
subjected to PH.  Mice that received bone marrow from TNFα or IL-6 knockout mice had 
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decreased rates of hepatocyte DNA synthesis compared to those that received transplants 
from wild-type mice.  
 
Figure 1.4 KC Prime Hepatocytes to Enter the Cell Cycle. Upon activation, KC 
secrete TNFα, which stimulates the secretion of IL-6.  IL-6 binds to receptors on 
hepatocytes and stimulates expression of genes necessary for hepatocyte cell cycle 
progression. 
Role of MCP-1 in Monocyte Recruitment and Macrophage Activation 
During inflammatory responses, resident macrophages in injured tissue become 
activated, and additional monocytes are recruited from the bone marrow and circulation 
to the injured tissue, where they differentiate into activated macrophages.  Monocyte 
recruitment occurs in response to chemokines, which are proteins that regulate white 
blood cell trafficking as well as inflammation (Mantovani et al., 2004; Rossi & Zlotnik, 
2000).  Chemokines are categorized based on the position of cysteine (C) residues at the 
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N-terminus: CC, CXC, C, and CX3C (Deshmane, Kremlev, Amini, & Sawaya, 2009; 
Mantovani et al., 2004).   
The first human CC chemokine discovered was monocyte chemoattractant 
protein-1 (MCP-1), also known as CC-chemokine ligand-2 (CCL2) (Yadav, Saini, & 
Arora, 2010).  Regulated at the transcriptional level, MCP-1 expression is induced by a 
variety of stimuli, including LPS and changes in blood flow (Taub, 2004; Uguccioni, 
Dapuzzo, Loetscher, Dewald, & Baggiolini, 1995). During liver regeneration, MCP-1 
appears to be primarily produced by Kupffer cells, but it can also be secreted by hepatic 
stellate cells and endothelial cells (Marra, 2002).   
MCP-1 works through a G-protein coupled receptor, CCR2, which is expressed 
on the surface of many leukocytes, including monocytes, T-cells, and NK cells 
(Deshmane et al., 2009). Although at least three MCP-1 receptors exist, CCR2 is the 
primary receptor for MCP-1 in mice (Charo et al., 1994).  CCR2 is expressed on Kupffer 
cells (Deshmane et al., 2009), which can be activated and recruited to sites of 
inflammation by MCP-1 (Boring et al., 1997; Kurihara, Warr, Loy, & Bravo, 1997).   
In the liver, MCP-1 expression is increased during chronic hepatitis, inflammation 
and fibrosis (Czaja, Geerts, Xu, Schmiedeberg, & Ju, 1994; Marra, 2002; Marra et al., 
1998), and inactivation of MCP-1 has been shown to attenuate liver injury by inhibiting 
macrophage recruitment (Imamura, Ogawa, Sasaguri, Chayama, & Ueno, 2005; Zamara 
et al., 2007).  Impaired monocyte migration has also been reported for mice that lack 
CCR2 (Boring et al., 1997).  However, little is known about the consequences of MCP-
1/CCR2 signaling during PH-induced liver regeneration.   
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Hypothesis 
Given the significance of MCP-1 to monocyte recruitment and macrophage 
activation, we hypothesized that this chemokine is important for activating monocytes 
and resident KC during liver regeneration.  We took advantage of the availability of 
transgenic mice to determine how MCP-1 expression and CCR2 expression contribute to 
hepatocyte proliferation during PH-induced liver regeneration.  The specific aims of the 
study were as follows: 
1) To characterize MCP-1 expression during liver regeneration in wild-type mice. 
2) To determine if MCP-1/CCR2 is required for monocyte recruitment, macrophage 
activation, and hepatocyte proliferation during liver regeneration. 
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CHAPTER 2: MATERIALS AND METHODS  
Mice 
Female C57Bl/6 (wild-type), MCP-1 knockout (KO) (strain B6.129S4-
Ccl2tm1Rol/J), and CCR2 KO (strain B6.129S4-Ccr2tm1Ifc/J) mice were purchased from the 
Jackson Lab (Bar Harbor, ME) and used at 8-9 weeks of age.  MCP-1 and CCR2 KO 
mice are fertile and display no gross physical or behavioral abnormalities. Furthermore, 
numbers of macrophages (peritoneal, alveolar, and Kupffer cells) in these KO mice are 
similar to levels found in wild type mice (Boring et al., 1997; Lu et al., 1998).  Mice were 
housed in a temperature-controlled facility on a 12-hr light/dark cycle with unlimited 
access to food and water. Mice were anesthetized with inhaled isoflurane, and 70% PH 
was performed as previously described (Mitchell, Lockhart, Huang, & Elferink, 2006). 
After euthanasia, blood was collected at the axillary plexus, plasma was recovered by 
centrifugation, and remnant liver tissue was collected.  The experimental protocol was 
approved by the Animal Studies Subcommittee and the Research and Development 
Committee of the Boise VA Medical Center (Boise, ID), where the animals were housed.  
All animals received humane care according to the criteria outlined in the "Guide for the 
Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and 
published by the National Institutes of Health. 
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Measurement of MCP-1 Levels 
At each time point, tissues from 3–5 mice were used to measure MCP-1 mRNA 
levels in the liver and MCP-1 protein levels in liver homogenates and plasma.  To 
measure hepatic MCP-1 mRNA levels, total RNA was isolated from frozen liver tissue 
using an RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer’s 
protocol.  cDNA was synthesized using SuperScript II reverse transcriptase (Invitrogen, 
Carlsbad, CA).  Transcript levels were measured by quantitative real-time PCR (qRT-
PCR) at the Molecular Genomics Core at the University of Texas Medical Branch 
(Galveston, TX).  To measure MCP-1 protein levels in the liver, frozen liver tissue was 
homogenized in PBS containing 0.5% Triton X-100 0.05% sodium azide, and protease 
inhibitors.  MCP-1 levels were measured in liver homogenates by ELISA (Thermo 
Scientific Pierce, Rockford, IL) and expressed as pg per mg liver protein, based on a 
Lowry protein assay (Bio-Rad, Hercules, CA).  Plasma levels of MCP-1 were measured 
using a Cytometric Bead Array (BD Biosciences, San Diego, CA) according to the 
manufacturer’s instructions.  Unpooled plasma samples were run in duplicate.  
Quantification of F4/80+ Cells by Immunohistochemistry 
Paraffin-embedded liver tissue was incubated with proteinase K for 3 minutes to 
retrieve antigen.  Tissue was then incubated overnight with a biotinylated rat-anti-mouse 
F4/80 antibody (Invitrogen, Carlsbad, CA) and visualized using an anti-rat HRP-DAB 
Cell and Tissue Staining Kit (R&D Systems, Minneapolis, MN).  Eight fields of 400X 
magnification were counted from each mouse. 
  
 
20 
Measurement of TNFα and IL-6 Production by ELISA 
Levels of TNFα and IL-6 were measured in unpooled plasma samples using 
sandwich enzyme-linked immunosorbent assay kits (Pierce Biotech, Rockford, IL). The 
assays were performed according to the manufacturer’s instructions, and all samples were 
run in duplicate.  The lower limit of detection for the assays was 50 pg/ml. 
Measurement of Stat3 Activation by Western Blot 
Frozen liver tissue was mechanically homogenized as described elsewhere 
(Mitchell et al., 2006). Cellular debris was pelleted at 10,000 X g, and protein 
concentration was determined by using a Lowry protein assay (Bio-Rad, Hercules, CA).  
Homogenates (25-50 µg protein/lane) were fractionated by SDS-PAGE and transferred to 
polyvinylidene difluoride membranes for western blot analysis with anti-STAT3 and anti-
phosphorylated STAT3 antibodies (Cell Signaling Technology, Danvers, MA).  
BrdU Labeling and Detection 
To measure hepatocyte proliferation, mice were injected intraperitoneally with 50 
mg/kg bromodeoxyuridine (BrdU; Sigma-Aldrich, St. Louis, MO) two hours prior to 
euthanasia.  In a separate experiment, continuous BrdU labeling was achieved by 
administering BrdU in the drinking water (0.8 mg/ml).  Water bottles containing BrdU 
were protected from light and replenished daily until mice were killed 6 days 
postoperatively.  After euthanasia, fresh liver tissue was fixed in UltraLight™ fixative 
(Bi-Biomics, Nampa, ID), paraffin-embedded, and processed for immunohistochemical 
staining.  Tissue sections (5-um) were incubated with a biotinylated anti-BrdU antibody 
(Invitrogen, Carlsbad, CA) followed by avidin-conjugated horseradish peroxidase and the 
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substrate 3,3’-diaminobenzidine (DAB).  Sections were counterstained with hematoxylin.  
For each animal, at least five random 400X fields were examined, and a total of 800-1000 
nuclei were counted.   The number of brown (DAB)-stained nuclei (BrdU+) was 
expressed as a percentage of total number of nuclei. 
Detection of CCR2+ Cells by Immunofluorescence Staining 
Paraffin-embedded tissue sections (5-µm) were processed and cut for 
immunofluorescence staining.  Antigen retrieval was carried out in sodium citrate buffer 
at 95°C for 15 minutes.  Sections were incubated with a rabbit monoclonal anti-CCR2 
antibody (Novus, Littleton, CO) followed by a FITC-conjugated goat anti-rabbit antibody 
(BD Biosciences, San Diego, CA).  CCR2+ cells were visualized using a fluorescent 
microscope. 
Detection of CCR2+ Cells by Flow Cytometry 
Nonparenchymal cells were isolated from the liver and analyzed by flow 
cytometry.  Briefly, livers were perfused with Hank’s Buffered Salt Solution (HBSS) 
containing 50 mM EDTA, transferred to RPMI 1640 with 2.5% FBS, minced into a 
slurry, and poured through a nylon cell strainer.  Samples were centrifuged at 60 x g for 1 
min at room temperature (RT), and pellets containing hepatocytes were discarded. 
Samples were then centrifuged at 500 x g for 10 min at room temperature.  Resulting 
pellets were re-suspended in Percoll in RPMI 1640 without FBS and centrifuged at 850 x 
g, 30 min at room temperature.  Pellets were depleted of red blood cells by hypotonic 
lysis, and remaining cells were resuspended in PBS containing 1% fetal bovine serum.  
Cells were then incubated with Fc-Receptor Block (BD Biosciences, San Jose, CA) for 10 
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min before staining with a rabbit monoclonal anti-CCR2 antibody (Novus, Littleton, CO) 
followed by a FITC-conjugated goat anti-rabbit antibody (BD Biosciences, San Diego, 
CA).  Stained cells were analyzed on an Accuri C6 flow cytometer (Ann Arbor, MI).  At 
least 50,000 events (viable cells) were collected from unpooled samples and analyzed 
using Accuri CFlow Plus software.  
Statistical Analysis 
Data were analyzed using Prism (version 4.0, GraphPad Software, San Diego, CA).  
Data were evaluated by one-way ANOVA followed by a Dunnett’s post-hoc test, or by 
two-way ANOVA and Bonferroni post-hoc test.  Data were considered significantly 
different at p ≤ 0.05.  
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CHAPTER 3: RESULTS 
MCP-1 Levels Increase After PH 
To examine MCP-1 production after PH, MCP-1 mRNA levels were quantified in 
the remnant liver, and protein levels were measured in liver homogenates and plasma. 
Hepatic MCP-1 mRNA levels peaked 90 minutes after PH (Fig. 3.1A), followed by 
increased MCP-1 protein expression in the regenerating liver 4 hr and 6 hr after PH (Fig. 
3.1B).  A four-fold increase in circulating MCP-1 was detected in the plasma 12 hr after 
PH (Fig. 3.1C).  
 
Figure 3.1 MCP-1 Levels Increase After PH.  A: MCP-1 mRNA levels in the 
regenerating liver at the indicated times after PH.  MCP-1 mRNA levels (mean +/- SEM) 
are expressed as fold-induction relative to expression of 18S rRNA in the same samples 
(n=3).  B: MCP-1 protein levels in the liver after PH.  MCP-1 levels (mean +/- SEM) in 
liver homogenates were normalized to the total amount of protein in each sample (n=3-5).  
C: MCP-1 protein levels (mean +/- SEM) in the plasma after PH (n=3-6).   * P < 0.05 
when compared to 0-hr group based on one-way ANOVA followed by Dunnett’s test. 
MCP-1 is Not Required for Recruitment of Hepatic F4/80+ Macrophages 
It has been demonstrated that hepatic-derived MCP-1 stimulates the expansion and 
egress of a population of F4/80+ monocytes in the bone marrow (Crane, Hokeness-
Antonelli, & Salazar-Mather, 2009). Hence, we hypothesized that MCP-1 is important for 
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recruiting bone marrow-derived monocytes to the regenerating liver and that numbers of 
hepatic macrophages would be decreased in the absence of MCP-1. Using wild type and 
MCP-1 knockout (KO) mice, we performed a cursory examination of liver macrophages 
based on expression of F4/80 antigen. Contrary to our hypothesis, no changes in F4/80 
expression were detected in the regenerating liver of wild type and MCP-1 KO mice (Fig. 
3.2).  
 
Figure 3.2 Number of Macrophages is Similar in the Liver of Wild Type and 
MCP-1 KO Mice.  Data represent average number of F4/80+ cells (+/- SEM) in the 
regenerating liver of wild type and MCP-1 knockout mice at the indicated times after PH.  
The number of F4/80+ cells was counted in 8 separate 40x fields per mouse from 3-5 
mice per treatment group.  
MCP-1 is Not Required for TNFα or IL-6 Production During Liver Regeneration 
During the priming phase of liver regeneration, the production of TNFα and IL-6 is 
attributed to activated Kupffer cells (Taub, 2004).  Kupffer cells express the MCP-1 
receptor, CCR2, and have been shown to become activated in response to MCP-1 in other 
model systems (Marra, 2002).  Hence, we hypothesized that MCP-1 may influence the 
production of Kupffer cell-derived cytokines during liver regeneration.  However, 
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measurement of plasma cytokine levels revealed no difference in TNFα or IL-6 production 
between wild type and MCP-1 KO mice (Fig. 3.3).  Hepatic mRNA levels of these 
cytokines were below the limit of detection (data not shown). 
 
Figure 3.3 Levels of Kupffer Cell-Derived Cytokines are Similar in Wild Type 
and MCP-1 KO Mice.  Data represent plasma levels (mean +/- SEM) of TNFα and IL-6 
in wild type and MCP-1 KO mice at the indicated times after PH.  Cytokines were 
measured in unpooled plasma samples by ELISA (n=3-5) and run in duplicate. 
MCP-1 is Not Required for Priming of Hepatocytes During Liver Regeneration 
The production of TNFα and IL-6 by Kupffer cells is implicated in priming 
hepatocytes for cell cycle progression (Aldeguer et al., 2002). Upon binding to its cognate 
receptor on hepatocytes, IL-6 activates Stat3 signaling pathways, leading to gene 
expression that facilitates hepatocyte proliferation.  Hence, Stat3 activation is a pivotal 
step in regeneration that is likely to be dependent on macrophage activation.  Our results 
indicate that hepatic levels of phosphorylated Stat3 increased 6 and 12 hr after PH in both 
wild type and MCP-1 KO mice, suggesting that MCP-1 is not necessary for hepatocyte 
priming during liver regeneration (Fig. 3.4).   
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Figure 3.4 MCP-1 is Not Required for Stat3 Activation During Liver 
Regeneration. Representative western blot analysis of Stat3 and phosphorylated-Stat3 
proteins in the regenerating liver of wild type and MCP-1 KO mice at the indicated times 
after PH (20 µg protein/lane). 
MCP-1 is Not Required for Hepatocyte Proliferation After PH 
Finally, we investigated the ramifications of MCP-1 production on the regenerative 
capacity of the liver.  No differences in liver-body weight ratios were detected between 
wild type and MCP-1 KO mice (Fig. 3.5A).  Pulse labeling with BrdU revealed that robust 
hepatocyte proliferation occurred 36 and 48 hr after PH in wild-type mice and was not 
suppressed in MCP-1 KO mice (Fig. 3.5B).  Likewise, continuous BrdU administration 
revealed no overt differences in BrdU incorporation in the regenerating liver of wild type 
and MCP-1 KO mice 6 days post-PH (Fig. 3.5C and 3.5D). 
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Figure 3.5 MCP-1 is Not Required for Hepatocyte Proliferation After PH.  A: 
Liver-body weight ratios (mean +/- SEM) of wild type and MCP-1 KO mice at the 
indicated times after PH (n=4-10). B: Percentage (mean +/- SEM) of BrdU+ hepatocyte 
nuclei from wild type or MCP-1 KO mice at the indicated times after PH.  Mice were 
pulsed with BrdU 2 hr prior to euthanasia at the indicated time points (n=6-10).  C: 
Representative BrdU incorporation in regenerating liver tissue from wild type and MCP-
1 KO mice 6 days after PH; BrdU was added to the drinking water continuously for 6 
days.  D: Cumulative BrdU incorporation in the regenerating liver of wild type and MCP-
1 KO mice administered BrdU in their drinking water for 6 days post-PH.  Data represent 
the percentage (mean +/- SEM) of BrdU+ hepatocyte nuclei from 4 mice per treatment 
group.   
MCP-1 is Not Required for Recruitment of CCR2+ Cells to the Regenerating Liver 
In addition to activating resident macrophages, MCP-1 may also recruit cells, such 
as bone-marrow-derived monocytes, to the damaged liver (Liaskou et al., 2012).  To 
investigate the possibility that cell recruitment was diminished in the absence of MCP-1, 
the prevalence of CCR2+ cells in the regenerating liver was measured.  
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Immunofluorescence staining revealed equivalent numbers of CCR2+ cells in the liver of 
wild-type and MCP-1 KO mice 12 hr after PH (Fig. 3.6A).  This finding was confirmed 
using flow cytometry, which revealed no changes in either the percent or total number of 
CCR2+ non-parenchymal cells in wild-type and MCP-1 KO mice (Fig. 3.6B).  
 
Figure 3.6 MCP-1 is Not Required for Recruitment of CCR2+ Cells to the 
Regenerating Liver.  A: Fluorescence microscopy was used to identify CCR2 expression 
in the liver of wild type and MCP-1 KO mice 12 hr after PH.  B: Flow cytometry was 
used to measure CCR2 expression in non-parenchymal cells isolated from the 
regenerating liver of wild type and MCP-1 KO mice 12 hour after PH.  Data represent the 
mean percentage and number (±SEM) of CCR2+ cells (n=4).  
Hepatocyte Proliferation is Suppressed in CCR2-Deficient Mice 
While MCP-1 is the most potent ligand of CCR2, there is redundancy in 
chemokine signaling such that MCP-3 and MCP-5 also bind this receptor, which could 
explain why liver regeneration was not impaired in the absence of MCP-1. To investigate 
the collective contribution of all CCR2 chemokines to regeneration, we compared PH-
induced hepatocyte proliferation between CCR2 KO and wild-type mice.  As shown in 
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Figure 3.7, levels of BrdU incorporation were reduced by about 40% in CCR2 KO mice 
36 hr after PH, although no statistically significant suppression was observed at 48 hr 
Reduced hepatocyte proliferation at 36 hr did not coincide with diminished liver-body 
weight ratios, which remained similar in CCR2 KO and wild-type mice at every time point 
tested. 
 
 
Figure 3.7 Hepatocyte Proliferation is Suppressed in CCR2-Deficient Mice.  A: 
Percentage (mean +/- SEM) of BrdU+ hepatocyte nuclei from wild type or CCR2 KO 
mice at the indicated times after PH.  Mice were pulsed with BrdU 2 hr prior to 
euthanasia at the indicated time points (n=3-4).  B: Liver-body weight ratios (mean +/- 
SEM) of wild type and CCR2 KO mice at the indicated times after PH.  * p<0.05 when 
compared to wild-type mice at same time point. 
A 
B 
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CHAPTER 4: DISCUSSION 
Macrophage activation is a crucial component of the early phase of liver 
regeneration following PH (Taub, 2004).  Given the well-characterized role of MCP-1 in 
activating macrophages and promoting macrophage infiltration, we hypothesized that 
MCP-1 would be important for macrophage activation during PH-induced liver 
regeneration.  However, data presented herein refute this hypothesis and demonstrate 
that, despite increased hepatic levels of MCP-1 after PH, this chemokine is not required 
for the production of macrophage-derived inflammatory cytokines or for hepatocyte 
proliferation. 
Increased MCP-1 expression has been observed in numerous models of liver 
injury and disease, such as administration of concanavalin A, carbon tetrachloride, and 
acetaminophen (Ajuebor, Hogaboam, Le, & Swain, 2003; James et al., 2005; Zamara et 
al., 2007).  Our results indicate that MCP-1 transcript levels increased just 90 min after 
PH, which confirms another report (Su et al., 2002).  Peak plasma levels of MCP-1 were 
detected at 12 hr in our study and were only slightly above basal levels.  It is unlikely that 
robust expression of MCP-1 occurs in the plasma before this time, as a recent report by 
Sgroi et al. demonstrates only scant levels of MCP-1 4 hr post-PH (Sgroi et al., 2011). 
Although Kupffer cells are a known source of MCP-1, it is likely that multiple cellular 
sources of MCP-1 exist in the regenerating liver (Hildebrand et al., 2006).  For instance, 
in a rat model of PH-induced liver regeneration, elevated MCP-1 mRNA levels were 
detected in hepatocytes, biliary epithelial cells, sinusoidal endothelial cells, Kupffer cells, 
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pit cells, and hepatic oval cells (Chen, Xu, Zhang, & Ma, 2010).  It is also possible that 
MCP-1 production could be attributed to inflammatory cells that infiltrate the liver after 
PH, such as bone marrow-derived monocytes/macrophages.  In fact, an intriguing report 
by Crane et al. (2009) indicates that F4/80+ bone marrow cells are an abundant source of 
MCP-1, as well as MCP-3 and MCP-5, during infection with murine cytomegalovirus 
(Crane et al., 2009).  Hence, during PH-induced liver regeneration, bone-marrow-derived 
monocytes could be an important source of MCP-1 in the bone marrow, during transit to 
the liver, or upon infiltration into hepatic tissue.   
MCP-1 expression has been shown to directly correlate with the number of 
infiltrating monocytes and macrophages in the liver (Marra et al., 1998), and inactivation 
of MCP-1 reportedly attenuates liver injury by inhibiting macrophage recruitment 
(Imamura et al., 2005; Marra et al. 2008, Zamara et al., 2007).  However, we found no 
difference in expression of the macrophage marker F4/80 in wild-type and MCP-1 
knockout mice.  Furthermore, plasma levels of TNFα and IL-6 were also similar, which 
indicates that macrophage activation was likely unaffected by the absence of MCP-1.  IL-
6 has been studied extensively as an important initiator of hepatocyte proliferation after 
PH, as regeneration is impaired and survival is reduced in IL-6-deficient mice subjected 
to PH (Blindenbacher et al., 2003; Kovalovich et al., 2000). Studies with IL-6 bone 
marrow chimeric mice demonstrate that, during liver regeneration, IL-6 is produced by 
bone marrow-derived, resident macrophages, rather than bone-marrow-derived stem cells 
that enter the liver and differentiate into parenchymal cells (Aldeguer et al., 2002). This 
leads us to conclude that MCP-1 is probably not required for Kupffer cell activation after 
PH.   
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During the priming phase of regeneration, IL-6 activates the signal transducer and 
activator of transcription-3 (STAT3) pathway, which upregulates immediate-early gene 
expression in hepatocytes and promotes responsiveness to growth factors (Li, Liang, 
Kellendonk, Poli, & Taub, 2002; Terui & Ozaki, 2005).  Given that levels of STAT3 
phosphorylation were similar in wild-type and MCP-1 knockout mice, it stands to reason 
that hepatocyte priming proceeds sufficiently despite the absence of MCP-1.  
Furthermore, continuous and pulse BrdU labeling revealed similar levels of hepatocyte 
proliferation in wild-type and MCP-1 knockout mice, which confirms that MCP-1 is 
dispensable for liver regeneration. 
Results from this study demonstrate comparable numbers of CCR2+ cells in the 
liver of wild-type and MCP-1 knockout mice.  We speculate that this was due to the 
activity of other CCR2 ligands, such as MCP-3 or MCP-5, which could essentially 
compensate for the absence of MCP-1.  However, the observation that liver regeneration 
was not overtly suppressed in CCR2 knockout mice renders this notion somewhat 
irrelevant.  In CCR2 KO mice, hepatocyte proliferation was suppressed 36 hr post-PH.  
However, this did not coincide with decreased liver-body weight ratios, and BrdU 
incorporation was comparable between CCR2 KO and wild-type mice at 48 hr post-PH.  
The suppression at 36 hr may result from diminished macrophage activity in the absence 
of CCR2, either through decreased monocyte recruitment to the liver or reduced 
activation of resident Kupffer cells.  Crane et al. (2009) demonstrated that CCR2 
activation in the bone marrow initiates the egress of CCR2+ monocytes into the 
circulation and to the liver.  Furthermore, they demonstrated that the CCR2+ Ly6Chigh 
inflammatory subpopulation of monocytes/macrophages accumulated in the bone marrow 
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during MCMV infection, and that the number of inflammatory monocytes/macrophages 
was diminished in CCR2-deficient mice.  Hence, it is possible that monocyte recruitment 
and/or macrophage activation is reduced in CCR2 knockout mice, leading to a transient 
suppression of hepatocyte proliferation.  Results from this study highlight the need to 
further investigate CCR2 signaling, as well as other chemokines receptors expressed in 
the bone marrow, as this could be a driving force that initiates the release of 
inflammatory monocytes/macrophages that are destined for the regenerating liver.  
Future studies could include elucidating the role of CCR2+ cells in the 
regenerative process by isolating them and studying gene expression at various times 
following PH.  Furthermore, the heterogeneity among this CCR2+ population can be 
further characterized using flow cytometry to determine if a specific subpopulation is 
critical to the regenerative process. Results from this project further our understanding of 
MCP-1/CCR2 signaling as it relates to inflammation and injury in the liver. This is an 
important endeavor for advancing our knowledge of liver disease and developing new 
therapeutic strategies to enhance recovery from liver disease. 
 
34 
REFERENCES 
Abshagen, K., Eipel, C., Kalff, J. C., Menger, M. D., & Vollmar, B. (2008). Kupffer 
Cells are Mandatory for Adequate Liver Regeneration by Mediating 
Hyperperfusion via Modulation of Vasoactive Proteins. Microcirculation, 15(1), 
37-47.  
Ajuebor, M. N., Hogaboam, C. M., Le, T., & Swain, M. G. (2003). C-C Chemokine 
Ligand 2/Monocyte Chemoattractant Protein-1 Directly Inhibits NKT Cell IL-4 
Production and is Hepatoprotective in T Cell-Mediated Hepatitis in the Mouse. 
Journal of Immunology, 170(10), 5252-5259.  
Aldeguer, X., Debonera, F., Shaked, A., Krasinkas, A. M., Gelman, A. E., Que, X. G., 
Olthoff, K. M. (2002). Interleukin-6 from Intrahepatic Cells of Bone Marrow 
Origin is Required for Normal Murine Liver Regeneration. Hepatology, 35(1), 
40-48. 
Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., 
Wong, W. W., & Yuan, J. Y. (1996). Human ICE/CED-3 Protease Nomenclature. 
Cell, 87(2), 171-171.  
Aoki, T., Imamura, H., Matsuyama, Y., Kishi, Y., Kobayashi, T., Sugawara, Y., Kokudo, 
N. (2011). Convergence Process of Volumetric Liver Regeneration After Living-
Donor Hepatectomy. Journal of Gastrointestinal Surgery, 15(9), 1594-1601.  
Assy, N., & Minuk, G. Y. (1997). Liver Regeneration: Methods for Monitoring and Their 
Applications. Journal of Hepatology, 26(4), 945-952.  
Baier, P. K., Baumgartner, U., Hempel, S., Wolff-Vorbeck, G., von Dobschuetz, E., & 
Hopt, U. T. (2005). Kupffer Cells Infiltrate Liver Tissue Early After Ischemia-
Reperfusion and Partial Hepatectomy. European Surgical Research, 37(5), 290-
297.  
 
35 
Bilzer, M., Roggel, F., & Gerbes, A. L. (2006). Role of Kupffer Cells in Host Defense 
and Liver Disease. Liver International, 26(10), 1175-1186.  
Blindenbacher, A., Wang, X. Y., Langer, I., Savino, R., Terracciano, L., & Heim, M. H. 
(2003). Interleukin 6 is Important for Survival After Partial Hepatectomy in Mice. 
Hepatology, 38(3), 674-682.  
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., 
& Charo, I. F. (1997). Impaired Monocyte Migration and Reduced Type 1 (Th1) 
Cytokine Responses in C-C Chemokine Receptor 2 Knockout Mice. Journal of 
Clinical Investigation, 100(10), 2552-2561.  
Charo, I., Myers, S., Herman, A., Franci, C., Connolly, A., & Coughlin, S. (1994). 
Molecular Cloning and Functional Expression of Two Monocyte Chemoattractant 
Protein 1 Receptors Reveals Alternative Splicing of the Carboxyl-Terminal Tails. 
Proc Natl Acad Sci U S A, 91(7), 2752-2756.  
Chen, X. G., Xu, C. S., Zhang, F. C., & Ma, J. (2010). Comparative Analysis of 
Expression Profiles of Chemokines, Chemokine Receptors, and Components of 
Signaling Pathways Mediated by Chemokines in Eight Cell Types During Rat 
Liver Regeneration. Genome, 53(8), 608-618.  
Chiang, J. Y. L. (2009). Bile Acids: Regulation of Synthesis. Journal of Lipid Research, 
50(10), 1955-1966.  
Columbano, A., Leddacolumbano, G. M., Ennas, M. G., Curto, M., Chelo, A., & Pani, P. 
(1990). Cell Proliferation and Promotion of Rat-Liver Carcinogenesis - Different 
Effect of Hepatic Regeneration and Mitogen Induce Hyperplasia on the 
Development of Enzyme-Altered Foci. Carcinogenesis, 11(5), 771-776. doi: 
10.1093/carcin/11.5.771 
Columbano, A., Leddacolumbano, G. M., Lee, G., Rajalakshmi, S., & Sarma, D. S. R. 
(1987). Inability of Mitogen-Induced Liver Hyperplasia to Support the Induction 
of Enzyme-Altered Islands Induce by Liver Carcinogens. Cancer Research, 
47(21), 5557-5559.  
 
36 
Crane, M. J., Hokeness-Antonelli, K. L., & Salazar-Mather, T. P. (2009). Regulation of 
Inflammatory Monocyte/Macrophage Recruitment from the Bone Marrow during 
Murine Cytomegalovirus Infection: Role for Type I Interferons in Localized 
Induction of CCR2 Ligands. Journal of Immunology, 183(4), 2810-2817.  
Czaja, M. J., Geerts, A., Xu, J., Schmiedeberg, P., & Ju, Y. (1994). Monocyte 
Chemoattractant Protein-1 (MCP-1) Expression Occurs in Toxic Rat Liver Injury 
and Human Liver Disease. Journal of Leukocyte Biology, 55(1), 120-126.  
DeLeve, L. D. (2013). Liver Sinusoidal Endothelial Cells and Liver Regeneration. 
Journal of Clinical Investigation, 123(5), 1861-1866.  
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009). Monocyte 
Chemoattractant Protein-1 (MCP-1): An Overview. Journal of Interferon and 
Cytokine Research, 29(6), 313-326.  
Dory, D., Echchannaoui, H., Letiembre, M., Ferracin, F., Pieters, J., Adachi, Y., Akashi, 
S., Zimmerli, W., Landmann, R. (2003) Generation and Functional 
Characterization of a Clonal Murine Periportal Kupffer Cell Line from H-2Kb–
tsA58 Mice. J Leukoc Biol. 4(1):49-59. 
Fausto, N. (2000). Liver Regeneration. Journal of Hepatology, 32, 19-31.  
Fausto, N., Campbell, J. S., & Riehle, K. J. (2006). Liver Regeneration. Hepatology, 
43(2), S45-S53.  
Friedman, S. L. (2008). Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic 
Cells of the Liver. Physiological Reviews, 88(1), 125–172.  
Fujihara, M., Muroi, M., Tanamoto, K., Suzuki, T., Azuma, H., & Ikeda, H. (2003). 
Molecular Mechanisms of Macrophage Activation and Deactivation by 
Lipopolysaccharide: Roles of the Receptor Complex. Pharmacology & 
Therapeutics, 100(2), 171-194.  
Greene, A. K., & Puder, M. (2003). Partial Hepatectomy in the Mouse: Technique and 
Perioperative Management. Journal of Investigative Surgery, 16(2), 99-102.  
 
37 
Hakkola, J., Tanaka, E., & Pelkonen, O. (1998). Developmental Expression of 
Cytochrome P450 Enzymes in Human Liver. Pharmacology & Toxicology, 82(5), 
209-217. 
Hildebrand, F., Hubbard, W.J., Choudhry, M.A., Frink, M., Pape, H.C., Kunkel, S.L., 
Chaudry I.H. (2006) Kupffer Cells and their Mediators: the Culprits in Producing 
Distant Organ Damage After Trauma-Hemorrhage. Am J Pathol; 169(3):784-94. 
Imamura, M., Ogawa, T., Sasaguri, Y., Chayama, K., & Ueno, H. (2005). Suppression of 
macrophage infiltration inhibits activation of hepatic stellate cells and liver 
fibrogenesis in rats. Gastroenterology, 128(1), 138-146.  
Isse, K., Harada, K., & Nakanuma, Y. (2007). IL-8 Expression by Biliary Epithelial Cells 
is Associated with Neutrophilic Infiltration and Reactive Bile Ductules. Liver 
International, 27(5), 672-680.  
James, L. P., Simpson, P. M., Farrar, H. C., Kearns, G. L., Wasserman, G. S., Blumer, J. 
L., Pediat Pharmacology Res Unit, N. (2005). Cytokines and Toxicity in 
Acetaminophen Overdose. Journal of Clinical Pharmacology, 45(10), 1165-1171. 
Katayanagi, K., Kono, N., & Nakanuma, Y. (1998). Isolation, Culture and 
Characterization of Biliary Epithelial Cells from Different Anatomical Levels of 
the Intrahepatic and Extrahepatic Biliary Tree From a Mouse. Liver, 18(2), 90-98.  
Kawser, C. A., Iredale, J. P., Winwood, P. J., & Arthur, M. J. P. (1998). Rat Hepatic 
Stellate Cell Expression of Alpha 2-Macroglobulin is a Feature of Cellular 
Activation: Implications for Matrix Remodelling in Hepatic Fibrosis. Clinical 
Science, 95(2), 179-186.  
Kountouras, J., Boura, P., & Lygidakis, N. J. (2001). Liver Regeneration After 
Hepatectomy. Hepato-Gastroenterology, 48(38), 556-562.  
Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., & Taub, R. (2000). 
Increased Toxin-Induced Liver Injury and Fibrosis in Interleukin-6-Deficient 
Mice. Hepatology, 31(1), 149-159.  
 
38 
Kurihara, T., Warr, G., Loy, J., & Bravo, R. (1997). Defects in Macrophage Recruitment 
and Host Defense in Mice Lacking the CCR2 Chemokine Receptor. Journal of 
Experimental Medicine, 186(10), 1757-1762.  
Li, W., Liang, X. P., Kellendonk, C., Poli, V., & Taub, R. (2002). STAT3 Contributes to 
the Mitogenic Response of Hepatocytes During Liver Regeneration. Journal of 
Biological Chemistry, 277(32), 28411-28417.  
Liaskou, E., Wilson, D., & Oo, Y. (2012) Innate Immune Cells in Liver Inflammation. 
Mediators of Inflammation, vol. 2012  
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., Rollins, B. J. 
(1998). Abnormalities in Monocyte Recruitment and Cytokine Expression in 
Monocyte Chemoattractant Protein 1-Deficient Mice. Journal of Experimental 
Medicine, 187(4), 601-608.  
Macias-Silva, M., Li, W., Leu, J. I., Crissey, M. A. S., & Taub, R. (2002). Up-Regulated 
Transcriptional Repressors SnoN and Ski Bind Smad Proteins to Antagonize 
Transforming Growth Factor-Beta Signals During Liver Regeneration. Journal of 
Biological Chemistry, 277(32), 28483-28490.  
Malato, Y., Naqvi, S., Schurmann, N., Ng, R., Wang, B., Zape, J., Willenbring, H. 
(2011). Fate Tracing of Mature Hepatocytes in Mouse Liver Homeostasis and 
Regeneration. Journal of Clinical Investigation, 121(12), 4850-4860. 
Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., & Locati, M. (2004). The 
Chemokine System in Diverse Forms of Macrophage Activation and Polarization. 
Trends in Immunology, 25(12), 677-686.  
Mao, S. A., Glorioso, J. M., & Nyberg, S. L. (2014). Liver Regeneration. Translational 
Research, 163(4), 352-362.  
Marra, F. (2002). Chemokines in Liver Inflammation and Fibrosis. Frontiers in 
Bioscience, 7, D1899-D1914.  
Marra, F., DeFranco, R., Grappone, C., Milani, S., Pastacaldi, S., Pinzani, M., Gentilini, 
P. (1998). Increased Expression of Monocyte Chemotactic Protein-1 During 
 
39 
Active Hepatic Fibrogenesis - Correlation with Monocyte Infiltration. American 
Journal of Pathology, 152(2), 423-430.  
Michalopoulos, G. K. (2010). Liver Regeneration After Partial Hepatectomy Critical 
Analysis of Mechanistic Dilemmas. American Journal of Pathology, 176(1), 2-13.  
Michalopoulos, G. K. (2013). Principles of Liver Regeneration and Growth Homeostasis. 
Comprehensive Physiology, 3(1), 485-513. doi: 10.1002/cphy.c120014 
Michalopoulos, G. K., & DeFrances, M. C. (1997). Liver Regeneration. Science, 
276(5309), 60-66.  
Minamino, T., Ito, Y., Ohkubo, H., Hosono, K., Suzuki, T., Sato, T., Majima, M. (2012). 
Thromboxane A(2) Receptor Signaling Promotes Liver Tissue Repair After Toxic 
Injury Through the Enhancement of Macrophage Recruitment. Toxicology and 
Applied Pharmacology, 259(1), 104-114.  
Mitchell, K. A., Lockhart, C. A., Huang, G. M., & Elferink, C. J. (2006). Sustained Aryl 
Hydrocarbon Receptor Activity Attenuates Liver Regeneration. Molecular 
Pharmacology, 70(1), 163-170.  
Mochida, S., Ohta, Y., Ogata, I., & Fujiwara, K. (1992). Gut-Derived Substances in 
Activation of Hepatic Macrophages After Partial-Hepatectomy in Rats. Journal of 
Hepatology, 16(3), 266-272.  
Nacu, E., & Tanaka, E. M. (2011). Limb Regeneration: A New Development? Annual 
Review of Cell and Developmental Biology, Vol 27, 27, 409-440.  
Naito, M., Hasegawa, G., & Takahashi, K. (1997). Development, Differentiation, and 
Maturation of Kupffer cells. Microscopy Research and Technique, 39(4), 350-
364.  
Nygard, I., Mortensen, K., Hedegaard, J., Conley, L., Kalstad, T., Bendixin, C., & 
Revhaug, A. (2012). The Genetic Regulation of the Terminating Phase of Liver 
Regeneration. Comparative Hepatology, 11(3).  
 
40 
Overturf, K., AlDhalimy, M., Ou, C. N., Finegold, M., & Grompe, M. (1997). Serial 
Transplantation Reveals the Stem-Cell-Like Regenerative Potential of Adult 
Mouse Hepatocytes. American Journal of Pathology, 151(5), 1273-1280.  
Power, C., & Rasko, J. E. J. (2008). Whither Prometheus' Liver? Greek Myth and the 
Science of Regeneration. Annals of Internal Medicine, 149(6), 421-W479.  
Ramadori, G., & Saile, B. (2002). Mesenchymal Cells in the Liver - One Cell Type or 
Two? Liver, 22(4), 283-294.  
Rossi, D., & Zlotnik, A. (2000). The Biology of Chemokines and their Receptors. Annual 
Review of Immunology, 18, 217-243.  
Selzner, N., Selzner, M., Odermatt, B., Tian, Y. H., Van Rooijen, N., & Clavien, P. A. 
(2003). ICAM-1 Triggers Liver Regeneration Through Leukocyte Recruitment 
and Kupffer Cell-Dependent Release of TNF-Alpha/IL-6 in Mice. 
Gastroenterology, 124(3), 692-700.  
Sgroi, A., Gonelle-Gispert, C., Morel, P., Baertschiger, R. M., Niclauss, N., Mentha, G., 
Buhler, L. (2011). Interleukin-1 Receptor Antagonist Modulates the Early Phase 
of Liver Regeneration after Partial Hepatectomy in Mice. Plos One, 6(9). 
Sharma, A. D., Cantz, T., Manns, M. P., & Ott, M. (2006). The Role of Stem Cells in 
Physiology, Pathophysiology, and Therapy of the Liver. Stem Cell Reviews, 2(1), 
51-58. 
Shiratori, Y., Hongo, S., Hikiba, Y., Ohmura, K., Nagura, T., Okano, K., Omata, M. 
(1996). Role of Macrophages in Regeneration of Liver. Digestive Diseases and 
Sciences, 41(10), 1939-1946.  
Sigal, S. H., Gupta, S., Gebhard, D. F., Holst, P., Neufeld, D., & Reid, L. M. (1995). 
Evidence for a Terminal Differentiatin Process in the Rat Liver. Differentiation, 
59(1), 35-42.  
Skrtic, S., Wallenius, V., Ekberg, S., Brenzel, A., Gressner, A. M., & Jansson, J. O. 
(1997). Insulin-Like Growth Factors Stimulate Expression of Hepatocyte Growth 
Factor but not Transforming Growth Factor Beta(1) in Cultured Hepatic Stellate 
Cells. Endocrinology, 138(11), 4683-4689.  
 
41 
Su, A., Guidotti, L., Pezacki, J., Chisari, F., Schultz, P. (2002). Gene Expression During 
the Priming Phase of Liver Regeneration After Partial Hepatectomy in Mice. 
Proceedings of the National Academy of Sciences, 99(17), 11181-11186.  
Sudo, K., Yamada, Y., Saito, K., Shimizu, S., Ohashi, H., Kato, T., Seishima, M. (2008). 
TNF-Alpha and IL-6 Signals From the Bone Marrow Derived Cells are Necessary 
for Normal Murine Liver Regeneration. Molecular Basis of Disease, 1782(11), 
671-679.  
Tacke, F., Luedde, T., & Trautwein, C. (2009). Inflammatory Pathways in Liver 
Homeostasis and Liver Injury. Clinical Reviews in Allergy & Immunology, 36(1), 
4-12.  
Taub, R. (2004). Liver Regeneration: From Myth to Mechanism. Nature Reviews 
Molecular Cell Biology, 5(10), 836-847.  
Terui, K., & Ozaki, M. (2005). The Role of STAT3 in Liver Regeneration. Drugs of 
Today, 41(7), 461-469.  
Uguccioni, M., Dapuzzo, M., Loetscher, M., Dewald, B., & Baggiolini, M. (1995).  
Actions of the Chemotactic Cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-
1-Alpha and MIP-1-Beta on Human Monocytes. European Journal of 
Immunology, 25(1), 64-68.  
Ukai, K., Terashima, K., Imai, Y., Shinzawa, H., Okuyama, Y., Takahashi, T., & 
Ishikawa, M. (1990). Proliferation Kinetics of Rat Kupffer Cells After Partial-
Hepatectomy - Immunohistochemical and Ultrastructural Analysis. Acta 
Pathologica Japonica, 40(9), 623-634.  
Wheatley, A. M., Rieder, H. U., Kuznetsova, L. V., Zhang, X. Y., Seiler, C., & Mathie, 
R. T. (1997). Effect of Liver Transplantation on Hepatic Hemodynamics: 
Methodology and Mechanisms. Digestive Surgery, 14(5), 344-354.  
Yadav, A., Saini, V., & Arora, S. (2010). MCP-1: Chemoattractant with a Role Beyond 
Immunity: A Review. Clinica Chimica Acta, 411(21-22), 1570-1579.  
 
42 
Zamara, E., Galastri, S., Aleffi, S., Petrai, I., Aragno, M., Mastrocola, R., Marra, F. 
(2007). Prevention of Severe Toxic Liver Injury and Oxidative Stress in MCP-1-
Deficient Mice. Journal of Hepatology, 46(2), 230-238.  
 
